Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Aprile, Giuseppe"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 31
Tytuł:
Baseline Albumin-Bilirubin grade as a predictor of response and outcome of regorafenib therapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis.
Autorzy:
Xu H; Department of Oncology, The Fifth Hospital of Wuhan, #122 Xianzheng Road, Hanyang District, Wuhan, 430000, China. .
Cao D; Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, China.
Zhou D; Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, China.
Zhao N; Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, China.
Tang X; Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, China.
Shelat VG; Department of General Surgery, Tan Tock Seng Hospital, Singapore, Singapore.
Samant H; Division of Hepatology, Ochsner Multi-Organ Transplant Center, New Orleans, LA, USA.
Satapathy SK; Division of Hepatology, Department of Medicine and Northwell Center for Liver Diseases & Transplantation, Northwell Health, Manhasset, NY, USA.
Tustumi F; Department of Gastroenterology, Digestive Surgery Division, University of São Paulo Medical School, Sao Paulo, Brazil.
Aprile G; Department of Oncology, San Bortolo General Hospital, Berica, Vicenza, Italy.
He A; Department of Oncology, The Fifth Hospital of Wuhan, #122 Xianzheng Road, Hanyang District, Wuhan, 430000, China.
Xu X; Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, China.
Ge W; Department of Oncology, Taikang Tongji Hospital of Wuhan, Wuhan, China.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Oct 19; Vol. 23 (1), pp. 1006. Date of Electronic Publication: 2023 Oct 19.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*
Liver Neoplasms*
Humans ; Bilirubin ; Serum Albumin ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Primary Tumor Resection for Metastatic Colorectal, Gastric and Pancreatic Cancer Patients: In Search of Scientific Evidence to Inform Clinical Practice.
Autorzy:
Fanotto V; Department of Oncology, Academic Hospital of Udine, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Piazzale Santa Maria della Misericordia, 33100 Udine, Italy.
Salani F; Unit of Oncology 2, Azienda Ospedaliero-Universitaria Pisana, 56126 Pisa, Italy.; Institute of Interdisciplinary Research 'Health Science', Scuola Superiore Sant'Anna, Piazza Martiri della Libertà 33, 56124 Pisa, Italy.
Vivaldi C; Unit of Oncology 2, Azienda Ospedaliero-Universitaria Pisana, 56126 Pisa, Italy.; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.
Scartozzi M; Unit of Medical Oncology, University Hospital, University of Cagliari, 09124 Cagliari, Italy.
Ribero D; Division of General and Oncologic Surgery Multimedica, A.O. Santa Croce e Carle, 12100 Cuneo, Italy.
Puzzoni M; Unit of Medical Oncology, University Hospital, University of Cagliari, 09124 Cagliari, Italy.
Montagnani F; Department of Oncology, Azienda Sanitaria Locale di Biella, 13900 Ponderano, Italy.
Leone F; Department of Oncology, Azienda Sanitaria Locale di Biella, 13900 Ponderano, Italy.
Vasile E; Unit of Oncology 2, Azienda Ospedaliero-Universitaria Pisana, 56126 Pisa, Italy.
Bencivenga M; General and Upper GI Surgery Division, Verona University (VR), 37134 Verona, Italy.
De Manzoni G; General and Upper GI Surgery Division, Verona University (VR), 37134 Verona, Italy.
Basile D; Department of Oncology, San Bortolo General Hospital, ULSS 8 Berica-Vicenza, 36100 Vicenza, Italy.
Fornaro L; Unit of Oncology 2, Azienda Ospedaliero-Universitaria Pisana, 56126 Pisa, Italy.
Masi G; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.
Aprile G; Department of Oncology, San Bortolo General Hospital, ULSS 8 Berica-Vicenza, 36100 Vicenza, Italy.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2023 Jan 31; Vol. 15 (3). Date of Electronic Publication: 2023 Jan 31.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The SAFFO Study: Sex-Related Prognostic Role and Cut-Off Definition of Monocyte-to-Lymphocyte Ratio (MLR) in Metastatic Colorectal Cancer.
Autorzy:
Lisanti C; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.
Basile D; Department of Medical Oncology, San Giovanni di Dio Hospital, 88900 Crotone, Italy.
Garattini SK; Department of Oncology, ASUFC University Hospital, 33100 Udine, Italy.
Parnofiello A; Sandro Pitigliani Medical Oncology Department, Hospital of Prato, 59100 Prato, Italy.
Corvaja C; Department of Medicine (DAME), University of Udine, 33100 Udine, Italy.
Cortiula F; Department of Oncology, ASUFC University Hospital, 33100 Udine, Italy.
Bertoli E; Department of Medicine (DAME), University of Udine, 33100 Udine, Italy.
Ongaro E; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.
Foltran L; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.
Casagrande M; Department of Oncology, ASUFC University Hospital, 33100 Udine, Italy.
Di Nardo P; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.
Cardellino GG; Department of Oncology, ASUFC University Hospital, 33100 Udine, Italy.
Fasola G; Department of Oncology, ASUFC University Hospital, 33100 Udine, Italy.
Buonadonna A; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.
Pella N; Department of Oncology, ASUFC University Hospital, 33100 Udine, Italy.
Aprile G; Department of Medical Oncology, San Bortolo Hospital, Azienda ULSS8 Berica, 36100 Vicenza, Italy.
Puglisi F; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.; Department of Medicine (DAME), University of Udine, 33100 Udine, Italy.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Dec 28; Vol. 15 (1). Date of Electronic Publication: 2022 Dec 28.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma.
Autorzy:
Rimini M; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute Hospital, Vita-Salute San Raffaele University, Via Olgettina n. 60, Milan, Italy. .
Fabregat-Franco C; Gastrointestinal Cancer Unit, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Burgio V; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute Hospital, Vita-Salute San Raffaele University, Via Olgettina n. 60, Milan, Italy.
Lonardi S; Oncology Unit 3, Veneto Institute of Oncology-IRCCS, Padua, Italy.
Niger M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Scartozzi M; Medical Oncology, University and University Hospital, Cagliari, Italy.
Rapposelli IG; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', 47014, Meldola, Italy.
Aprile G; Department of Oncology, San Bortolo General Hospital, Azienda ULSS8 Berica, Vicenza, Italy.
Ratti F; Hepatobiliary Surgery Division, Liver Center, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, 20132, Milan, Italy.
Pedica F; Pathology Unit, Department of Experimental Oncology, IRCCS San Raffaele Scientific Institute, 20132, Milan, Italy.
Verdaguer H; Gastrointestinal Cancer Unit, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Rizzato M; Oncology Unit 1, Veneto Institute of Oncology-IRCCS, Padua, Italy.
Nichetti F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Lai E; Medical Oncology, University and University Hospital, Cagliari, Italy.
Cappetta A; Department of Oncology, San Bortolo General Hospital, Azienda ULSS8 Berica, Vicenza, Italy.
Macarulla T; Gastrointestinal Cancer Unit, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Fassan M; Surgical Pathology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy.; Veneto Institute of Oncology-IRCCS, Padua, Italy.
De Braud F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Medical Oncology, University and University Hospital, Cagliari, Italy.; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', 47014, Meldola, Italy.; Department of Oncology, San Bortolo General Hospital, Azienda ULSS8 Berica, Vicenza, Italy.; Hepatobiliary Surgery Division, Liver Center, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, 20132, Milan, Italy.; Pathology Unit, Department of Experimental Oncology, IRCCS San Raffaele Scientific Institute, 20132, Milan, Italy.; Oncology Unit 1, Veneto Institute of Oncology-IRCCS, Padua, Italy.; Surgical Pathology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy.; Veneto Institute of Oncology-IRCCS, Padua, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Pretta A; Medical Oncology, University and University Hospital, Cagliari, Italy.
Simionato F; Department of Oncology, San Bortolo General Hospital, Azienda ULSS8 Berica, Vicenza, Italy.
De Cobelli F; School of Medicine, Vita-Salute San Raffaele University, 20132, Milan, Italy.
Aldrighetti L; Hepatobiliary Surgery Division, Liver Center, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, 20132, Milan, Italy.
Fornaro L; School of Medicine, Vita-Salute San Raffaele University, 20132, Milan, Italy.
Cascinu S; Department of Oncology, IRCCS San Raffaele Scientific Institute Hospital, Vita-Salute San Raffaele University, Milan, Italy.
Casadei-Gardini A; Department of Oncology, IRCCS San Raffaele Scientific Institute Hospital, Vita-Salute San Raffaele University, Milan, Italy.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Nov 05; Vol. 12 (1), pp. 18775. Date of Electronic Publication: 2022 Nov 05.
Typ publikacji:
Journal Article
MeSH Terms:
Cholangiocarcinoma*/pathology
Bile Duct Neoplasms*/pathology
Humans ; Mutation ; Prognosis ; Bile Ducts, Intrahepatic/pathology ; Carrier Proteins/genetics ; Isocitrate Dehydrogenase/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The impact of age, performance status and comorbidities on nab-paclitaxel plus gemcitabine effectiveness in patients with metastatic pancreatic cancer.
Autorzy:
Catalano M; Department of Human Health Sciences, School of Human Health Sciences, University of Florence, Largo Brambilla 3, 50134, Florence, Italy. .
Aprile G; Department of Oncology, San Bortolo General Hospital, AULSS8 Berica, Vicenza, Italy.
Conca R; Division of Medical Oncology, Department of Onco-Hematology, IRCCS-CROB, Referral Cancer Center of Basilicata, via Padre Pio 1, 85028, Rionero, Vulture, PZ, Italy.
Petrioli R; Department of Medicine, Surgery and Neurosciences, Medical Oncology Unit, University of Siena, VialeBracci-Policlinico'LeScotte', 53100, Siena, Italy.
Ramello M; Oncology Unit, Department of Medical, Surgical and Health Sciences, University of Trieste, Piazza Ospitale, Trieste, Italy.
Roviello G; Department of Health Sciences, University of Florence, viale Pieraccini, 6, 50139, Florence, Italy.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 May 17; Vol. 12 (1), pp. 8244. Date of Electronic Publication: 2022 May 17.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols*/adverse effects
Pancreatic Neoplasms*/pathology
Aged ; Albumins ; Comorbidity ; Deoxycytidine/analogs & derivatives ; Humans ; Paclitaxel ; Treatment Outcome ; Gemcitabine
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy.
Autorzy:
Filippi R; Department of Oncology, University of Turin, Torino, Italy.; Division of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Centro Oncologico Ematologico Subalpino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.
Montagnani F; Division of Medical Oncology, ASL BI, Nuovo Ospedale degli Infermi, Ponderano, Italy.
Lombardi P; Department of Oncology, University of Turin, Torino, Italy.; Division of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
Fornaro L; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
Aprile G; Department of Oncology, University Hospital of Udine, Udine, Italy.; Department of Oncology, San Bortolo General Hospital, AULSS8, Vicenza, Italy.
Casadei-Gardini A; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy.; Department of Oncology and Haematology, University Hospital of Modena, Italy.
Faloppi L; Medical Oncology Unit, Macerata General Hospital, Macerata, Italy.
Palloni A; Department of Experimental, Diagnostic and Specialty Medicine, University Hospital S. Orsola-Malpighi, Bologna, Italy.
Satolli MA; Department of Oncology, University of Turin, Torino, Italy.; Centro Oncologico Ematologico Subalpino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.
Scartozzi M; Department of Medical Oncology, University Hospital, Cagliari, Italy.
Citarella F; Department of Medical Oncology, Campus Bio-Medico University, Roma, Italy.
Lutrino SE; Department of Oncology, Ospedale Vito Fazzi, Lecce, Italy.
Vivaldi C; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Italy.
Silvestris N; Medical Oncology Unit, IRCCS Cancer Institute 'Giovanni Paolo II', Bari, Italy.; Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari, Italy.
Rovesti G; Department of Oncology and Haematology, University Hospital of Modena, Italy.
Rimini M; Department of Oncology and Haematology, University Hospital of Modena, Italy.
Aglietta M; Department of Oncology, University of Turin, Torino, Italy.; Division of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
Brandi G; Department of Experimental, Diagnostic and Specialty Medicine, University Hospital S. Orsola-Malpighi, Bologna, Italy.
Leone F; Division of Medical Oncology, ASL BI, Nuovo Ospedale degli Infermi, Ponderano, Italy.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2021 Oct; Vol. 60 (10), pp. 1317-1324. Date of Electronic Publication: 2021 Jul 20.
Typ publikacji:
Journal Article
MeSH Terms:
Bile Duct Neoplasms*
Biliary Tract Neoplasms*/drug therapy
Antineoplastic Combined Chemotherapy Protocols ; Humans ; Lymphocytes ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Drug Holidays and Overall Survival of Patients with Metastatic Colorectal Cancer.
Autorzy:
Garattini SK; Department of Oncology, ASUFC University Hospital of Udine, 33100 Udine, Italy.
Basile D; Department of Oncology, San Bortolo General Hospital, 36100 Vicenza, Italy.
Bonotto M; Department of Oncology, ASUFC University Hospital of Udine, 33100 Udine, Italy.
Ongaro E; Department of Medical Oncology, Unit of Medical Oncology and Cancer Prevention, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy.
Porcu L; Laboratory of Methodology for Clinical Research, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.
Corvaja C; Department of Medicine, University of Udine, 33100 Udine, Italy.
Cattaneo M; Department of Medicine, University of Udine, 33100 Udine, Italy.
Andreotti VJ; Department of Medicine, University of Udine, 33100 Udine, Italy.
Lisanti C; Department of Medicine, University of Udine, 33100 Udine, Italy.
Bertoli E; Department of Medicine, University of Udine, 33100 Udine, Italy.
Pelizzari G; Department of Oncology, ASUFC University Hospital of Udine, 33100 Udine, Italy.
Iacono D; Department of Oncology, ASUFC University Hospital of Udine, 33100 Udine, Italy.
Miolo G; Department of Medical Oncology, Unit of Medical Oncology and Cancer Prevention, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy.
Cardellino GG; Department of Oncology, ASUFC University Hospital of Udine, 33100 Udine, Italy.
Buonadonna A; Department of Medical Oncology, Unit of Medical Oncology and Cancer Prevention, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy.
Aprile G; Department of Oncology, San Bortolo General Hospital, 36100 Vicenza, Italy.
Fasola G; Department of Oncology, ASUFC University Hospital of Udine, 33100 Udine, Italy.
Puglisi F; Department of Medical Oncology, Unit of Medical Oncology and Cancer Prevention, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy.; Department of Medicine, University of Udine, 33100 Udine, Italy.
Pella N; Department of Oncology, ASUFC University Hospital of Udine, 33100 Udine, Italy.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Jul 13; Vol. 13 (14). Date of Electronic Publication: 2021 Jul 13.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase II INFINITY Study.
Autorzy:
Raimondi A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milano, Italy.
Palermo F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milano, Italy.
Prisciandaro M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milano, Italy.
Aglietta M; Medical Oncology Unit, Candiolo Cancer Institute-FPO, IRCCS, 10060 Candiolo, Italy.
Antonuzzo L; Clinical Oncology Unit, Careggi University Hospital, 50139 Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy.
Aprile G; Department of Clinical Oncology, Azienda ULSS 8 Berica-Ospedale di Vicenza, 36100 Vinceza, Italy.
Berardi R; Department of Clinical Oncology, Università Politecnica delle Marche-AOU Ospedali Riuniti di Ancona, 60126 Ancona, Italy.
Cardellino GG; Department of Oncology, Presidio Ospedaliero 'Santa Maria della Misericordia'-ASUFC, 33100 Udine, Italy.
De Manzoni G; Department of Surgery, Azienda Ospedaliero Universitaria Integrata di Verona-Borgo Trento, 37126 Verona, Italy.
De Vita F; Medical Oncology Unit, Azienda Ospedaliero Universitaria dell'Università degli Studi della Campania 'Luigi Vanvitelli', 80131 Naples, Italy.
Di Maio M; Department of Oncology, Ospedale Mauriziano Umberto I, 10128 Turin, Italy.
Fornaro L; Medical Oncology 2, Azienda Ospedaliero Universitaria Pisana, 56126 Pisa, Italy.
Frassineti GL; Department of Medical Oncology, Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori'(IRST)-IRCCS, 47014 Meldola, Italy.
Granetto C; Medical Oncology, Azienda Ospedaliera S. Croce e Carle, 12100 Cuneo, Italy.
Iachetta F; Department of Medical Oncology, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy.
Lonardi S; Department of Clinical and Experimental Oncology, IRCCS Istituto Oncologico Veneto, 35128 Padua, Italy.
Murialdo R; Medical Oncology, Ospedale Policlinico San Martino, 16132 Genoa, Italy.
Ongaro E; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano, Italy.
Pucci F; Medical Oncology Unit, Azienda Ospedaliero Universitaria di Parma, 43126 Parma, Italy.
Ratti M; Oncology Department, Azienda Socio-Sanitaria Territoriale di Cremona, 26100 Cremona, Italy.
Silvestris N; Department of Molecular Medicine, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, 15731 Tabriz, Iran.; Medical Oncology Unit, IRCCS Istituto Tumori 'Giovanni Paolo II' of Bari, 70124 Bari, Italy.
Smiroldo V; Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, 20089 Milan, Italy.
Spallanzani A; Medical Oncology Unit, Azienda Ospedaliero Universitaria di Modena, 41125 Modena, Italy.
Strippoli A; Medical Oncology Unit, Policlinico Universitario A. Gemelli, 00168 Rome, Italy.
Tamberi S; Medical Oncology, Azienda USL Della Romagna, 48018 Faenza, Italy.
Tamburini E; Medical Oncology Unit, Azienda Ospedaliera Cardinale G. Panico, 73039 Tricase, Italy.
Zaniboni A; Department of Medical Oncology, Fondazione Poliambulanza, 25124 Brescia, Italy.
Di Bartolomeo M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milano, Italy.
Cremolini C; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.
Sposito C; Gastrointestinal Surgery and Liver Transplantation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Mazzaferro V; Gastrointestinal Surgery and Liver Transplantation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Pietrantonio F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milano, Italy.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Jun 07; Vol. 13 (11). Date of Electronic Publication: 2021 Jun 07.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Association between Low-Grade Chemotherapy-Induced Peripheral Neuropathy (CINP) and Survival in Patients with Metastatic Adenocarcinoma of the Pancreas.
Autorzy:
Catalano M; School of Human Health Sciences, University of Florence, Largo Brambilla 3, 50134 Florence, Italy.
Aprile G; Department of Oncology, San Bortolo General Hospital, AULSS8 Berica, 36100 Vicenza, Italy.
Ramello M; Oncology Unit, Department of Medical, Surgical & Health Sciences, University of Trieste, Piazza Ospitale, 34100 Trieste, Italy.
Conca R; Division of Medical Oncology, Department of Onco-Hematology, IRCCS-CROB, Referral Cancer Center of Basilicata, via Padre Pio 1, 85028 Rionero, Vulture (PZ), Italy.
Petrioli R; Department of Medicine, Surgery and Neurosciences, Medical Oncology Unit, University of Siena, Viale Bracci-Policlinico 'Le Scotte', 53100 Siena, Italy.
Roviello G; Department of Health Sciences, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2021 Apr 23; Vol. 10 (9). Date of Electronic Publication: 2021 Apr 23.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Case Report: A Metabolic Complete Response to Upfront Osimertinib in a Smoker Non-Small Cell Lung Cancer Patient Harbouring EGFR G719A/V769M Complex Mutation.
Autorzy:
Simionato F; Department of Oncology, San Bortolo General Hospital, Vicenza, Italy.
Calvetti L; Department of Oncology, San Bortolo General Hospital, Vicenza, Italy.
Cosci M; Department of Surgery, San Bortolo General Hospital, Vicenza, Italy.
Scarparo S; Pneumology Unit, San Bortolo General Hospital, Vicenza, Italy.
Aprile G; Department of Oncology, San Bortolo General Hospital, Vicenza, Italy.
Pokaż więcej
Źródło:
OncoTargets and therapy [Onco Targets Ther] 2020 Nov 23; Vol. 13, pp. 12027-12031. Date of Electronic Publication: 2020 Nov 23 (Print Publication: 2020).
Typ publikacji:
Case Reports
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality?
Autorzy:
Dell'Aquila E; Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy.
Zeppola T; Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy.
Stellato M; Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy.
Pantano F; Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy.
Scartozzi M; Medical Oncology, University Hospital and University of Cagliari, Cagliari, Italy.
Madaudo C; Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy.
Pietrantonio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Cremolini C; Unit of Medical Oncology 2, Department of Translational Research and New Technologies in Medicine and Surgery, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.
Aprile G; Department of Oncology, San Bortolo General Hospital, Vicenza, Italy.
Vincenzi B; Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy.
Moretto R; Unit of Medical Oncology 2, Department of Translational Research and New Technologies in Medicine and Surgery, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.
Puzzoni M; Medical Oncology, University Hospital and University of Cagliari, Cagliari, Italy.
Garattini SK; Department of Oncology, University Hospital of Udine, Udine, Italy.
Lobefaro R; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Tonini G; Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy.
Santini D; Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy.
Pokaż więcej
Źródło:
Clinical Medicine Insights. Oncology [Clin Med Insights Oncol] 2020 Aug 04; Vol. 14, pp. 1179554920946693. Date of Electronic Publication: 2020 Aug 04 (Print Publication: 2020).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
TP53 Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard Chemotherapy.
Autorzy:
Graziano F; Medical Oncology Unit, Azienda, Ospedali Riuniti Marche Nord, 61121 Pesaro, Italy.
Fischer NW; Genetics & Genome Biology Program, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.
Bagaloni I; Department of Biomolecular Sciences, Università degli Studi di Urbino, 61032 Fano, Italy.
Di Bartolomeo M; Department of Medical Oncology, Istituto Nazionale dei Tumori di Milano, 20133 Milan, Italy.
Lonardi S; Veneto Institute of Oncology IOV-IRCCS, 35128 Padova, Italy.
Vincenzi B; Department of Oncology, Campus Bio-Medico University, 00128 Rome, Italy.
Perrone G; Department of Oncology, Campus Bio-Medico University, 00128 Rome, Italy.
Fornaro L; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, 56126 Pisa, Italy.
Ongaro E; Department of Oncology, University and General Hospital, 33100 Udine, Italy.; Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.
Aprile G; Department of Oncology, San Bortolo General Hospital, 36100 Vicenza, Italy.
Bisonni R; Medical Oncology Unit, Hospital of Fermo, 63900 Fermo, Italy.
Prisciandaro M; Department of Medical Oncology, Istituto Nazionale dei Tumori di Milano, 20133 Milan, Italy.
Malkin D; Genetics & Genome Biology Program, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.; Division of Hematology-Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada.
Gariépy J; Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada.; Physical Sciences, Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada.
Fassan M; Veneto Institute of Oncology IOV-IRCCS, 35128 Padova, Italy.
Loupakis F; Veneto Institute of Oncology IOV-IRCCS, 35128 Padova, Italy.
Sarti D; Medical Oncology Unit, Azienda, Ospedali Riuniti Marche Nord, 61121 Pesaro, Italy.
Del Prete M; Medical Oncology Unit, Hospital of Fermo, 63900 Fermo, Italy.
Catalano V; Medical Oncology Unit, Azienda, Ospedali Riuniti Marche Nord, 61121 Pesaro, Italy.
Alessandroni P; Medical Oncology Unit, Azienda, Ospedali Riuniti Marche Nord, 61121 Pesaro, Italy.
Magnani M; Department of Biomolecular Sciences, Università degli Studi di Urbino, 61032 Fano, Italy.
Ruzzo A; Department of Biomolecular Sciences, Università degli Studi di Urbino, 61032 Fano, Italy.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2020 Jul 24; Vol. 12 (8). Date of Electronic Publication: 2020 Jul 24.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer.
Autorzy:
Antoniotti C; Department of Oncology, University Hospital of Pisa, Pisa, Italy.; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
Borelli B; Department of Oncology, University Hospital of Pisa, Pisa, Italy.; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
Rossini D; Department of Oncology, University Hospital of Pisa, Pisa, Italy.; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
Pietrantonio F; Oncology and Hemato-Oncology Department, University of Milan, Milano, Italy.; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Morano F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Salvatore L; Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.; Università Cattolica del Sacro Cuore, Roma, Italy.
Lonardi S; Medical Oncology Unit 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto - IRCCS, Padova, Italy.
Marmorino F; Department of Oncology, University Hospital of Pisa, Pisa, Italy.; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
Tamberi S; Medical Oncology, Ospedale degli Infermi, Faenza, Italy.
Corallo S; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Tortora G; Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.; Università Cattolica del Sacro Cuore, Roma, Italy.
Bergamo F; Medical Oncology Unit 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto - IRCCS, Padova, Italy.
Brunella DS; Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.; Università Cattolica del Sacro Cuore, Roma, Italy.
Boccaccino A; Department of Oncology, University Hospital of Pisa, Pisa, Italy.; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
Grassi E; Medical Oncology, Ospedale degli Infermi, Faenza, Italy.
Racca P; SSD ColoRectal Cancer Unit, Department of Oncology, AOU Città della Salute e della Scienza di Torino, Torino, Italy.
Tamburini E; Department of Oncology and Palliative Care, Cardinale G. Panico, Tricase City Hospital, Tricase, Italy.
Aprile G; Department of Oncology, San Bortolo General Hospital, ULSS8 Berica, East District, Vicenza, Italy.
Moretto R; Department of Oncology, University Hospital of Pisa, Pisa, Italy.
Boni L; Clinical Trials Coordinating Center, Toscano Cancer Institute, University Hospital Careggi, Firenze, Italy.
Falcone A; Department of Oncology, University Hospital of Pisa, Pisa, Italy.; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
Cremolini C; Department of Oncology, University Hospital of Pisa, Pisa, Italy. .; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2020 Jul 22; Vol. 20 (1), pp. 683. Date of Electronic Publication: 2020 Jul 22.
Typ publikacji:
Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Antibodies, Monoclonal, Humanized/*administration & dosage
Antineoplastic Agents/*administration & dosage
Antineoplastic Agents, Immunological/*administration & dosage
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Bevacizumab/*administration & dosage
Camptothecin/*analogs & derivatives
Colorectal Neoplasms/*drug therapy
Aged ; Camptothecin/administration & dosage ; Colorectal Neoplasms/genetics ; Colorectal Neoplasms/pathology ; Drug Administration Schedule ; Fluorouracil/administration & dosage ; Humans ; Italy ; Leucovorin/administration & dosage ; Microsatellite Instability ; Organoplatinum Compounds/administration & dosage ; Prospective Studies
SCR Protocol:
FOLFOXIRI protocol
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer.
Autorzy:
Salati M; Department of Oncology and Hematology, Division of Oncology, University of Modena and Reggio Emilia, Modena, Italy.
Filippi R; Department of Oncology, University of Turin, Turin, Italy.; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
Vivaldi C; Department of Oncology, University of Pisa, Pisa, Italy.
Caputo F; Department of Oncology and Hematology, Division of Oncology, University of Modena and Reggio Emilia, Modena, Italy.
Leone F; Department of Oncology, University of Turin, Turin, Italy.; SC Oncologia ASL Biella, Biella, Italy.
Salani F; Department of Oncology, University of Pisa, Pisa, Italy.
Cerma K; Department of Oncology and Hematology, Division of Oncology, University of Modena and Reggio Emilia, Modena, Italy.
Aglietta M; Department of Oncology, University of Turin, Turin, Italy.; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
Fornaro L; Department of Oncology, University of Pisa, Pisa, Italy.
Sperti E; Department of Oncology, University of Turin, Turin, Italy.; Oncologia Medica AO Ordine Mauriziano, Turin, Italy.
Di Maio M; Department of Oncology, University of Turin, Turin, Italy.; Oncologia Medica AO Ordine Mauriziano, Turin, Italy.
Ortega C; Medical Oncology, ASL CN2 Alba Bra, Alba, Italy.
Fenocchio E; Department of Oncology, University of Turin, Turin, Italy.; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
Lombardi P; Department of Oncology, University of Turin, Turin, Italy.; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
Cagnazzo C; Department of Public Health and Pediatrics, University of Turin, Turin, Italy.; City of Health and Science Hospital of Turin, Pediatric Oncoematology, Regina Margherita Children's Hospital, Turin, Italy.
Depetris I; SC Medical Oncology 1, Istituto Oncologico Veneto - IRCCS, Padova, Italy.
Gelsomino F; Department of Oncology and Hematology, Division of Oncology, University of Modena and Reggio Emilia, Modena, Italy.
Spallanzani A; Department of Oncology and Hematology, Division of Oncology, University of Modena and Reggio Emilia, Modena, Italy.
Santini D; Department of Medical Oncology, Università Campus Bio-Medico, Rome, Italy.
Silvestris N; Department of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro, Bari, Italy.; Medical Oncology Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
Aprile G; Department of Oncology, San Bortolo General Hospital, Vicenza, Italy.
Roviello G; Department of Health Sciences, University of Florence, Florence, Italy.
Scartozzi M; Medical Oncology Unit, University of Cagliari, Cagliari, Italy.
Cascinu S; Department of Oncology and Hematology, Division of Oncology, University of Modena and Reggio Emilia, Modena, Italy.
Casadei-Gardini A; Department of Oncology and Hematology, Division of Oncology, University of Modena and Reggio Emilia, Modena, Italy.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2020 Mar; Vol. 40 (3), pp. 704-711. Date of Electronic Publication: 2019 Dec 11.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasms*
Nutrition Assessment*
Humans ; Prognosis ; ROC Curve ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer Aged at Least 75 Years: A Post-Hoc Subgroup Analysis of Three Phase II Trials.
Autorzy:
Rosati G; U.O. Oncologia Medica, Azienda Ospedaliera S. Carlo, 85100 Potenza, Italy. .
Cordio S; Struttura Complessa di Oncologia Medica, Ospedale Garibaldi, 95122 Catania, Italy. .
Reggiardo G; Biostatistics and Data Management Unit, Medi Service S.r.l., 16149 Genova, Italy. .
Aprile G; Dipartimento di Oncologia Clinica, Ospedale San Bortolo, AULSS8, 36100 Vicenza, Italy. giuseppe.aprile@aulss8.veneto.it.
Butera A; U.O. Oncologia Medica, Ospedale S. Giovanni di Dio, 92100 Agrigento, Italy. .
Avallone A; Struttura Complessa di Oncologia Clinica Sperimentale Addome, Dipartimento Assistenziale e di Ricerca dei Percorsi Oncologici del Distretto Addominale, Istituto Nazionale per lo Studio e la Cura dei Tumori 'Fondazione Giovanni Pascale' - IRCCS, 80131 Napoli, Italy. .
Tucci A; U.O. Oncologia Medica, ASL NA3 Sud, 80035 Nola (NA), Italy. .
Novello G; U.O. Oncologia Medica, Azienda Ospedaliero-Universitaria 'Vittorio Emanuele', 95124 Catania, Italy. giuseppe..
Blanco G; U.O. Oncologia Medica, Istituto Oncologico del Mediterraneo, 95029 Viagrande (CT), Italy. .
Caputo G; U.O. Oncologia Medica, Azienda Ospedaliera Gravina, 95041 Caltagirone, Italy. .
Bilancia D; U.O. Oncologia Medica, Azienda Ospedaliera S. Carlo, 85100 Potenza, Italy. .
Bordonaro R; Struttura Complessa di Oncologia Medica, Ospedale Garibaldi, 95122 Catania, Italy. .
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2019 Apr 24; Vol. 11 (4). Date of Electronic Publication: 2019 Apr 24.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR.
Autorzy:
Peraldo-Neia C; Medical Oncology, Fondazione del Piemonte per l'Oncologia (FPO), IRCCS-Institute of Candiolo, Candiolo, Italy.
Cavalloni G; Medical Oncology, Fondazione del Piemonte per l'Oncologia (FPO), IRCCS-Institute of Candiolo, Candiolo, Italy.
Fenocchio E; Department of Oncology, University of Turin, IRCCS-Institute of Candiolo, Candiolo, Italy.
Cagnazzo C; Clinical Research Office, Fondazione del Piemonte per l'Oncologia (FPO), IRCCS-Institute of Candiolo, Candiolo, Italy.
Gammaitoni L; Medical Oncology, Fondazione del Piemonte per l'Oncologia (FPO), IRCCS-Institute of Candiolo, Candiolo, Italy.
Cereda S; Department of Medical Oncology IRCCS Ospedale San Raffaele, Milan, Italy.
Nasti G; Department of Abdominal Oncology, National Cancer Institute 'G. Pascale', Naples, Italy.
Satolli MA; Medical Oncology Division 1, University Hospital 'Città della Salute e della Scienza', Turin, Italy.
Aprile G; Department of Oncology, San Bortolo Hospital ULSS8-East District, Vicenza, Italy.
Reni M; Department of Medical Oncology IRCCS Ospedale San Raffaele, Milan, Italy.
Avallone A; Department of Abdominal Oncology, National Cancer Institute 'G. Pascale', Naples, Italy.
Spadi R; Medical Oncology Division 1, University Hospital 'Città della Salute e della Scienza', Turin, Italy.
Venesio T; Pathology Unit, Fondazione del Piemonte per l'Oncologia (FPO), IRCCS-Institute of Candiolo, Candiolo, Italy.
Martin V; Institute of Pathology, Locarno, Switzerland.
Doglioni C; Pathology Unit, IRCCS Ospedale San Raffaele, Milan, Italy.
Frattini M; Institute of Pathology, Locarno, Switzerland.
Aglietta M; Medical Oncology, Fondazione del Piemonte per l'Oncologia (FPO), IRCCS-Institute of Candiolo, Candiolo, Italy.; Department of Oncology, University of Turin, IRCCS-Institute of Candiolo, Candiolo, Italy.
Leone F; Medical Oncology, Fondazione del Piemonte per l'Oncologia (FPO), IRCCS-Institute of Candiolo, Candiolo, Italy.; Department of Oncology, University of Turin, IRCCS-Institute of Candiolo, Candiolo, Italy.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2018 Jan 19; Vol. 13 (1), pp. e0191593. Date of Electronic Publication: 2018 Jan 19 (Print Publication: 2018).
Typ publikacji:
Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Genes, erbB-1*
Mutation*
Biliary Tract Neoplasms/*drug therapy
Biliary Tract Neoplasms/*genetics
ErbB Receptors/*genetics
Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Bile Duct Neoplasms/drug therapy ; Bile Duct Neoplasms/genetics ; Bile Duct Neoplasms/metabolism ; Biliary Tract Neoplasms/metabolism ; Cholangiocarcinoma/drug therapy ; Cholangiocarcinoma/genetics ; Cholangiocarcinoma/metabolism ; DNA Mutational Analysis ; Deoxycytidine/administration & dosage ; Deoxycytidine/analogs & derivatives ; Deoxycytidine/therapeutic use ; ErbB Receptors/antagonists & inhibitors ; ErbB Receptors/metabolism ; Gallbladder Neoplasms/drug therapy ; Gallbladder Neoplasms/genetics ; Gallbladder Neoplasms/metabolism ; Gene Amplification ; Humans ; In Situ Hybridization, Fluorescence ; Kaplan-Meier Estimate ; Organoplatinum Compounds/administration & dosage ; Organoplatinum Compounds/therapeutic use ; Oxaliplatin ; Panitumumab ; Prognosis ; Gemcitabine
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Orthodontic management by functional activator treatment: a case report.
Autorzy:
Aprile G; Giuseppe Aprile, Freelance Doctor of Dental Surgery (DDS), Rome, Italy.
Ortu E; MeSVA Department, Division of Dentistry, University of L'Aquila, P. le Salvatore Tommasi, 67100, L'Aquila, Italy. .
Cattaneo R; MeSVA Department, Division of Dentistry, University of L'Aquila, P. le Salvatore Tommasi, 67100, L'Aquila, Italy.
Pietropaoli D; MeSVA Department, Division of Dentistry, University of L'Aquila, P. le Salvatore Tommasi, 67100, L'Aquila, Italy.
Giannoni M; MeSVA Department, Division of Dentistry, University of L'Aquila, P. le Salvatore Tommasi, 67100, L'Aquila, Italy.
Monaco A; MeSVA Department, Division of Dentistry, University of L'Aquila, P. le Salvatore Tommasi, 67100, L'Aquila, Italy.
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2017 Dec 02; Vol. 11 (1), pp. 336. Date of Electronic Publication: 2017 Dec 02.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Orthodontic Appliances, Functional*
Malocclusion, Angle Class II/*therapy
Orthodontics, Corrective/*methods
Child ; Humans ; Male ; Malocclusion, Angle Class II/diagnosis ; Orthodontic Retainers ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Panitumumab use in metastatic colorectal cancer and patterns of RAS testing: results from a Europe-wide physician survey and medical records review.
Autorzy:
Han van Krieken J; Radboud University Medical Center, Nijmegen, Netherlands. .
Kafatos G; Amgen Ltd, Uxbridge, UK.
Bennett J; Amgen Ltd, Uxbridge, UK.
Mineur L; Institute Sainte Catherine, Avignon, France.
Tomášek J; Masaryk Memorial Cancer Institute, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Rouleau E; Curie Institute, Paris, France.
Fabian P; Masaryk Memorial Cancer Institute, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
De Maglio G; University and General Hospital, Udine, Italy.
García-Alfonso P; Gregorio Marañón Hospital, Madrid, Spain.
Aprile G; University and General Hospital, Udine, Italy.
Parkar P; Amgen Ltd, Uxbridge, UK.
Downey G; Amgen Ltd, Cambridge, UK.
Demonty G; Amgen GmbH, Zug, Switzerland.
Trojan J; University Hospital, Frankfurt, Germany.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2017 Nov 28; Vol. 17 (1), pp. 798. Date of Electronic Publication: 2017 Nov 28.
Typ publikacji:
Journal Article; Multicenter Study; Review
MeSH Terms:
Antibodies, Monoclonal/*therapeutic use
Antineoplastic Agents/*therapeutic use
Colorectal Neoplasms/*drug therapy
GTP Phosphohydrolases/*genetics
Membrane Proteins/*genetics
Proto-Oncogene Proteins p21(ras)/*genetics
Colorectal Neoplasms/genetics ; Europe ; Female ; Genetic Testing ; Guideline Adherence ; Humans ; Male ; Medical Records ; Neoplasm Metastasis ; Panitumumab ; Physicians ; Practice Guidelines as Topic ; Practice Patterns, Physicians' ; Surveys and Questionnaires
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group.
Autorzy:
Cremolini C; Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Oncologia Medica 2 Universitaria, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, 56126, Pisa, Italy.
Marmorino F; Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Oncologia Medica 2 Universitaria, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, 56126, Pisa, Italy.
Loupakis F; Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Oncologia Medica 2 Universitaria, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, 56126, Pisa, Italy.
Masi G; Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Oncologia Medica 2 Universitaria, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, 56126, Pisa, Italy.
Antoniotti C; Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Oncologia Medica 2 Universitaria, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, 56126, Pisa, Italy.
Salvatore L; Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Oncologia Medica 2 Universitaria, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, 56126, Pisa, Italy.
Schirripa M; Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Oncologia Medica 2 Universitaria, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, 56126, Pisa, Italy.
Boni L; Centro per il Coordinamento per le Sperimentazioni Cliniche, Istituto Toscano Tumori, AOU Careggi, viale Pieraccini 6, 50139, Florence, Italy.
Zagonel V; Oncologia Medica 1, Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), via Gattamelata 64, 35128, Padua, Italy.
Lonardi S; Oncologia Medica 1, Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), via Gattamelata 64, 35128, Padua, Italy.
Aprile G; Dipartimento di Oncologia, Azienda Ospedaliero-Universitaria Santa Maria della Misericordia, Piazzale Santa Maria della Misericordia 15, 33100, Udine, Italy.
Tamburini E; Ospedale Infermi, Via Coriano 38, 47924, Rimini, Italy.
Ricci V; Oncologia Medica, Dipartimento di Oncologia Clinica, Azienda Sanitaria Ospedaliera S. Croce, Via Michele Coppino 26, 12100, Cuneo, Italy.
Ronzoni M; Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.
Pietrantonio F; Fondazione I.R.C.C.S, Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.
Valsuani C; Dipartimento Oncologico, A.S.L. 1 Carrara, P.zza Sacco e Vanzetti, 2, 54033, Carrara, Italy.
Tomasello G; SC Oncologia, Istituti Ospedalieri Di Cremona, Viale Concordia 1, 26100, Cremona, Italy.
Passardi A; Dipartimento di Oncologia Medica, IRCCS-IRST (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), via Piero Maroncelli 40, 47014, Meldola, FC, Italy.
Allegrini G; Oncologia Medica, Ospedale Felice Lotti, via Roma 147, 56025, Pontedera, Italy.
Di Donato S; Dipartimento Oncologico, AUSL 4 Prato, Via Mazzamuti 7, 59100, Prato, Italy.
Santini D; Oncologia Medica, Università Campus Bio-Medico, vai Alvaro del Portillo 200, 00128, Rome, Italy.
Falcone A; Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Oncologia Medica 2 Universitaria, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, 56126, Pisa, Italy. .
Pokaż więcej
Corporate Authors:
all the investigators of the Gruppo Oncologico del Nord Ovest
Źródło:
BMC cancer [BMC Cancer] 2017 Jun 09; Vol. 17 (1), pp. 408. Date of Electronic Publication: 2017 Jun 09.
Typ publikacji:
Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Research Design*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Bevacizumab/*therapeutic use
Colorectal Neoplasms/*therapy
Camptothecin/analogs & derivatives ; Camptothecin/therapeutic use ; Colorectal Neoplasms/drug therapy ; Colorectal Neoplasms/immunology ; Colorectal Neoplasms/pathology ; Disease-Free Survival ; Fluorouracil/therapeutic use ; Humans ; Leucovorin/therapeutic use ; Neoplasm Metastasis ; Organoplatinum Compounds/therapeutic use ; Prospective Studies ; Treatment Outcome
SCR Protocol:
FOLFOXIRI protocol; IFL protocol
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Wernicke encephalopathy and systemic sclerosis: rare association of rare conditions.
Autorzy:
Sciacca G; Section of Neurosciences, Department GF Ingrassia, University of Catania, Via Santa Sofia 78, 95123, Catania, Italy.
Fermo SL; Section of Neurosciences, Department GF Ingrassia, University of Catania, Via Santa Sofia 78, 95123, Catania, Italy.
Aprile G; Gastroenterology and Endoscopy Unit, University of Catania, Catania, Italy.
Nicoletti A; Section of Neurosciences, Department GF Ingrassia, University of Catania, Via Santa Sofia 78, 95123, Catania, Italy.
Zappia M; Section of Neurosciences, Department GF Ingrassia, University of Catania, Via Santa Sofia 78, 95123, Catania, Italy. .
Pokaż więcej
Źródło:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2017 Jan; Vol. 38 (1), pp. 203-205. Date of Electronic Publication: 2016 Sep 02.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Brain/*diagnostic imaging
Scleroderma, Systemic/*complications
Wernicke Encephalopathy/*complications
Aged ; Female ; Humans ; Magnetic Resonance Imaging ; Scleroderma, Systemic/diagnostic imaging ; Wernicke Encephalopathy/diagnostic imaging
Raport
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 31

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies